Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 1
2008 1
2011 2
2012 1
2013 2
2014 1
2015 2
2016 1
2017 1
2018 1
2020 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
[Pharmacology and classification of cyclooxygenase inhibitors].
Jouzeau JY, Daouphars M, Benani A, Netter P. Jouzeau JY, et al. Among authors: daouphars m. Gastroenterol Clin Biol. 2004 Apr;28 Spec No 3:C7-17. doi: 10.1016/s0399-8320(04)95274-8. Gastroenterol Clin Biol. 2004. PMID: 15366670 Free article. Review. French.
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines).
Slimano F, Baudouin A, Zerbit J, Toulemonde-Deldicque A, Thomas-Schoemann A, Chevrier R, Daouphars M, Madelaine I, Pourroy B, Tournamille JF, Astier A, Ranchon F, Cazin JL, Bardin C, Rioufol C. Slimano F, et al. Among authors: daouphars m. Cancer Treat Rev. 2020 Aug;88:102063. doi: 10.1016/j.ctrv.2020.102063. Epub 2020 Jun 23. Cancer Treat Rev. 2020. PMID: 32623296 Free PMC article. Review.
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M; European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Launay-Vacher V, et al. Among authors: daouphars m. Cancer Chemother Pharmacol. 2008 May;61(6):903-9. doi: 10.1007/s00280-008-0711-0. Epub 2008 Mar 4. Cancer Chemother Pharmacol. 2008. PMID: 18317762 Review.
SFPO and ESOP recommendations for the practical stability of anticancer drugs: an update.
Vigneron J, Astier A, Trittler R, Hecq JD, Daouphars M, Larsson I, Pourroy B, Pinguet F; French Society of Hospital Pharmacists; European Society of Oncology Pharmacists. Vigneron J, et al. Among authors: daouphars m. Ann Pharm Fr. 2013 Nov;71(6):376-89. doi: 10.1016/j.pharma.2013.06.002. Epub 2013 Aug 28. Ann Pharm Fr. 2013. PMID: 24206590
Impact of recommendations on crushing medications in geriatrics: from prescription to administration.
Bourdenet G, Giraud S, Artur M, Dutertre S, Dufour M, Lefèbvre-Caussin M, Proux A, Philippe S, Capet C, Fontaine-Adam M, Kadri K, Landrin I, Gréboval E, Touflet M, Nanfack J, Tharasse C, Varin R, Rémy E, Daouphars M, Doucet J. Bourdenet G, et al. Among authors: daouphars m. Fundam Clin Pharmacol. 2015 Jun;29(3):316-20. doi: 10.1111/fcp.12116. Epub 2015 Apr 15. Fundam Clin Pharmacol. 2015. PMID: 25789404
[Study impacto: Descriptive analyzis of pharmacist's clinical practice in onco-hematology].
Le Guen R, Madelaine I, Tournamille JF, Bellanger A, Astier A, Braguer D, Ollivier C, Bardin C, Lemare F, Daouphars M, Pinguet F, Latour JF, Vigneron J, Tilleul P. Le Guen R, et al. Among authors: daouphars m. Ann Pharm Fr. 2015 May;73(3):223-8. doi: 10.1016/j.pharma.2014.10.002. Epub 2014 Nov 12. Ann Pharm Fr. 2015. PMID: 25934530 French.
16 results